The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

Share Price Information for K3 Business Technology Group (KBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.50
Bid: 102.00
Ask: 105.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.941%)
Open: 103.50
High: 103.50
Low: 103.50
Prev. Close: 103.50
KBT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Announcement

6 Feb 2023 10:00

RNS Number : 0205P
K3 Business Technology Group PLC
06 February 2023
 

AIM: KBT

06 February 2023

 

K3 Business Technology Group plc

("K3", "Company" or "Group")

PDMR Announcement

K3, which provides businesscritical software solutions focused on fashion and apparel brands, has received notification from Kestrel Partners LLP ("Kestrel") that on 03 February 2023 it acquired, on behalf of its discretionary clients, 2,050 ordinary shares of 25p each ("Shares") in the Company at an average price of £1.10 per Share.

Mr Scott, a non-executive director of K3, is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in one of Kestrel's clients ("Kestrel Opportunities") and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in the Company.

Following these transactions, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 8,550,302 Shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest, hold 3,144,718 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 11,695,020 Shares in the Company, which represents 26.14% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

8,550,302

19.11%

Indirect

JIM Nominees Limited

270,529

0.60%

Indirect

Indirect

Bank of New York Nominees Ltd

Northern Trust Company AVFC

2,596,546

277,643

5.80%

0.63%

Further details in respect of the purchase are provided below, in accordance with the EU Market Abuse Regulation (No 596/2014).

 

For further information contact:

K3 Business Technology Group plc

+44 (0) 161 876 4498

Marco Vergani, CEO

Rob Price, CFO

finnCap Ltd

+44 (0) 207 220 0500

Nominated Adviser and Broker

 

Julian Blunt/Milesh Hindocha (Corporate Finance)

 

Sunila de Silva/Harriet Ward (Corporate Broking)

 

 

KTZ Communications

+44 (0) 20 3178 6378

 

Katie Tzouliadis/Dan Mahoney

 

 

 

 

ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Kestrel Partners LLP ('Kestrel')

2

Reason for the notification

a)

 

Position/status

 

PCA - Oliver Rupert Andrew Scott (non-executive director of K3 Business Technology Group plc and Partner in Kestrel)

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

K3 Business Technology Group plc

b)

LEI

213800QOJ9OF2AV81748

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

25p Ordinary Shares

 

 

 

ISIN: GB00B00P6061

b)

Nature of the transaction

Purchase

c)

 

Price(s) and volume(s)

 

 

03 February 2023

Price(s)

 

Volume(s)

£1.10

2,050 shares

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

Total purchase of 2,050 at an average of £1.10 per Share

 

 

 

e)

 

Date of the transaction

03 February 2023

f)

 

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDDCSGDGXL
Date   Source Headline
16th May 202210:42 amRNSPDMR Announcement
9th May 202212:47 pmRNSPDMR Announcement
3rd May 20223:07 pmRNSPDMR Announcement
22nd Apr 20227:00 amRNSNotice of AGM and Posting of Annual Report
12th Apr 20227:00 amRNSDirector/PDMR Shareholding
5th Apr 20227:00 amRNSBoard Retirement
5th Apr 20227:00 amRNSFinal Results
28th Feb 202212:06 pmRNSPDMR Announcement
14th Feb 20222:43 pmRNSPDMR Announcement
9th Feb 20223:00 pmRNSShare Option Scheme
7th Feb 20224:45 pmRNSHolding(s) in Company
7th Feb 20224:43 pmRNSPDMR Announcement
1st Feb 20229:03 amRNSPDMR Announcement
27th Jan 202212:50 pmRNSStrategic Acquisition of IP
23rd Dec 20215:05 pmRNSHolding(s) in Company
22nd Dec 20217:00 amRNSTrading Update
29th Nov 20215:36 pmRNSDirector/PDMR Shareholding
22nd Nov 20214:43 pmRNSPDMR Announcement
15th Nov 20212:30 pmRNSDirector/PDMR Shareholding
10th Nov 20215:06 pmRNSPDMR Announcement
18th Oct 202112:48 pmRNSPDMR Announcement
4th Oct 20213:00 pmRNSPDMR Announcement
27th Sep 20212:03 pmRNSPDMR Announcement
22nd Sep 202111:02 amRNSPDMR Announcement
20th Sep 20217:00 amRNSSale of Sage Business for £1.68m cash
26th Jul 20217:00 amRNSInterim Results
1st Jul 202111:37 amRNSHolding(s) in Company
21st Jun 20214:00 pmRNSPDMR Announcement
18th Jun 20214:54 pmRNSMarket Price Share Option Scheme
14th Jun 20218:08 amRNSPDMR Announcement
2nd Jun 202111:45 amRNSHolding(s) in Company
1st Jun 202110:46 amRNSPDMR Announcement
19th May 20211:30 pmRNSResult of AGM
12th May 20215:57 pmRNSDirector/PDMR Share Purchase
5th May 20211:43 pmRNSPDMR Announcement
4th May 20212:52 pmRNSDirector/PDMR Share Purchase
23rd Apr 20217:00 amRNSNotice of AGM and Posting of Annual Report
9th Apr 20212:49 pmRNSHolding(s) in Company
9th Apr 20212:47 pmRNSHolding(s) in Company
9th Apr 20212:46 pmRNSHolding(s) in Company
6th Apr 20214:59 pmRNSPDMR Announcement
30th Mar 20217:30 amRNSShareholder Loan Conversion
30th Mar 20217:30 amRNSLong Term Incentive Plan Option Scheme
30th Mar 20217:00 amRNSFinal Results
30th Mar 20217:00 amRNSAppointment of Chief Executive Officer
5th Mar 20217:00 amRNSBoard Change
1st Mar 20213:54 pmRNSHolding(s) in Company
26th Feb 20217:00 amRNSSale of subsidiary
13th Nov 20207:00 amRNSLong Term Incentive Plan
12th Nov 20207:00 amRNSPDMR Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.